On April 14, 2015 the Biotechnology Industry Organization (BIO) filed an amicus curiae brief with the Court of Appeals for the Federal Circuit1 in support of remand or reversal of the Amgen v. Sandoz ...
Tevogen Bio files additional AI-related patent to enhance drug discovery and develops T cell therapies for infectious diseases and cancers. Tevogen Bio, a clinical-stage biotech company specializing ...
PHILADELPHIA, Feb. 03, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China ...
Tevogen Bio files patent for T cell vaccine targeting entire viral genome, enhancing immune response against mutations and viral infections. Tevogen Bio, a clinical-stage immunotherapy biotech company ...
BALTIMORE, Jan. 12, 2026 /PRNewswire/ -- IndyGeneUS Bio today announced the filing of a patent application covering its Clinico-Genomic Insight Engine™ (CGIE™)—a foundational platform under ...
Local life science startup Boundless Bio filed Wednesday to go public — the first San Diego biotech to do so this year. It is the first initial public offering, or IPO, by a local life science firm in ...
MIAMI BEACH, Fla., July 26, 2024 /PRNewswire/ -- Immorta Bio Inc, a science-based longevity company dedicated to treating "Diseases of Aging and Aging as a Disease™" with personalized cellular ...
Gritstone bio (NASDAQ:GRTS) has filed for Chapter 11 bankruptcy protection in Delaware, according to a court filing. The California-based biotech intends to use the court-administered restructuring ...
GUANGZHOU, China--(BUSINESS WIRE)--Bio-Thera Solutions, a clinical-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of biosimilars, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results